Correlation the Components of Health Belief Model and the Intensity of Blood Tablets Consumption in Pre-Conception Mother

Abstract

Introduction and Objective: The high number of prevalence of anemia in women of childbearing age
has reached 22.7%. Anemia causes complication which increase maternal mortality rate, low birth weight,
and stunting. Government efforts to tackle anemia through the blood tablets program have not reduced
the prevalence of anemia. The coverage of blood tablets in pre-conception mothers in Tambakrejo Public
Health Center is still at a low level with 64.22%. The side effects of blood tablets such as nausea, vomiting,
constipation, and black defecation often make the consumers feel uncomfortable. Pre-conception mother
perceptions can be figured out by measuring instruments in the form of Health Belief Model (HBM). This
study was conducted to analyze the correlation the components of HBM and the intensity of blood tablet in
pre-conception mothers.
Material and Method: This study used an observational analytic method with a cross-sectional study
design. The samples were 37 pre-conception mothers were collected through random sampling technique.
The independent variables consisted of perceived susceptibility, severity, threats, benefits, barriers, and selfefficacy.
Meanwhile, the dependent variable was the intensity of blood tablets in pre-conception mothers.
This study also used questionnaires as an instrument. As for the data analysis, it was done using the Mc-
Nemar test.
Findings: Most pre-conception mothers have sufficient perceived of susceptibility (62.2%), severity
(54.1%), and threats (56.8%) of anemia as well as the benefits, barriers, and self-efficacy to consume blood
tablets (54.1%). Besides that, most of the pre-conception mothers (35.1%) have a low intensity in consuming
blood tablets. The Mc-Nemar test showed a p-value by <0.05.
Conclusion: There is a correlation the perceived of susceptibility, severity, threats, benefits, barriers, and
self-efficacy and the intensity of blood tablets in pre-conception mothers.